Macrophage dysfunction initiates colitis during weaning of infant mice lacking the interleukin-10 receptor

  1. Naresh S Redhu
  2. Vasudevan Bakthavatchalu
  3. Evan A Conaway
  4. Dror S Shoval
  5. Amy M Tsou
  6. Jeremy A Goettel
  7. Amlan Biswas
  8. Chuanwu Wang
  9. Michael Field
  10. Werner Muller
  11. Andre Bleich
  12. Ning Li
  13. Georg K Gerber
  14. Lynn Bry
  15. James G Fox
  16. Scott B Snapper  Is a corresponding author
  17. Bruce H Horwitz  Is a corresponding author
  1. Boston Children's Hospital, United States
  2. Massachusetts Institute of Technology, United States
  3. Brigham and Women's Hospital, United States
  4. University of Manchester, United Kingdom
  5. Hannover Medical School, Germany
  6. Harvard Medical School, United States

Abstract

Infants with defects in the interleukin 10 receptor (IL10R) develop very early onset inflammatory bowel disease. Whether IL10R regulates lamina propria macrophage function during infant development in mice and whether macrophage-intrinsic IL10R signaling is required to prevent colitis in infancy is unknown. Here we show that although signs of colitis are absent in IL10R-deficient mice during the first 2 weeks of life, intestinal inflammation and macrophage dysfunction begin during the 3rd week of life, concomitant with weaning and accompanying diversification of the intestinal microbiota. However, IL10R did not directly regulate the microbial ecology during infant development. Interestingly, macrophage depletion with clodronate inhibited the development of colitis, while the absence of IL10R specifically on macrophages sensitized infant mice to the development of colitis. These results indicate that IL10R-mediated regulation of macrophage function during the early postnatal period is indispensable for preventing the development of murine colitis.

Article and author information

Author details

  1. Naresh S Redhu

    Division of Gastroenterology, Hepatology and Nutrition, Boston Children's Hospital, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  2. Vasudevan Bakthavatchalu

    Division of Comparative Medicine, Massachusetts Institute of Technology, Cambridge, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Evan A Conaway

    Department of Pathology, Brigham and Women's Hospital, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Dror S Shoval

    Division of Gastroenterology, Hepatology and Nutrition, Boston Children's Hospital, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Amy M Tsou

    Division of Gastroenterology, Hepatology and Nutrition, Boston Children's Hospital, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Jeremy A Goettel

    Division of Gastroenterology, Hepatology and Nutrition, Boston Children's Hospital, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. Amlan Biswas

    Division of Gastroenterology, Hepatology and Nutrition, Boston Children's Hospital, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4299-1001
  8. Chuanwu Wang

    Division of Comparative Medicine, Massachusetts Institute of Technology, Cambridge, United States
    Competing interests
    The authors declare that no competing interests exist.
  9. Michael Field

    Division of Gastroenterology, Hepatology and Nutrition, Boston Children's Hospital, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  10. Werner Muller

    Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  11. Andre Bleich

    Institute for Laboratory Animal Science and Central Animal Facility, Hannover Medical School, Hannover, Germany
    Competing interests
    The authors declare that no competing interests exist.
  12. Ning Li

    Massachusetts Host-Microbiome Center, Department of Pathology, Brigham and Women's Hospital, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  13. Georg K Gerber

    Massachusetts Host-Microbiome Center, Department of Pathology, Brigham and Women's Hospital, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-9149-5509
  14. Lynn Bry

    Massachusetts Host-Microbiome Center, Department of Pathology, Brigham and Women's Hospital, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  15. James G Fox

    Division of Comparative Medicine, Massachusetts Institute of Technology, Cambridge, United States
    Competing interests
    The authors declare that no competing interests exist.
  16. Scott B Snapper

    Division of Gastroenterology, Hepatology and Nutrition, Boston Children's Hospital, Boston, United States
    For correspondence
    Scott.Snapper@childrens.harvard.edu
    Competing interests
    The authors declare that no competing interests exist.
  17. Bruce H Horwitz

    Harvard Medical School, Boston, United States
    For correspondence
    bhorwitz@partners.org
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-8123-8728

Funding

Crohn's and Colitis Foundation of America (RFA381023)

  • Naresh S Redhu

Canadian Institutes of Health Research (201411MFE-339308-254788)

  • Naresh S Redhu

National Institutes of Health (T32-OD010978-26)

  • James G Fox

Leona M. and Harry B. Helmsley Charitable Trust

  • Scott B Snapper

Wolpow Family Chair in IBD Research and Treatment

  • Scott B Snapper

National Institutes of Health (R01-OD011141)

  • James G Fox

National Institutes of Health (P30-ES002109)

  • James G Fox

National Institutes of Health (R01-AI00114)

  • Bruce H Horwitz

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: All experiments were conducted following approval from the Animal Resources at Children's Hospital, per regulations of the Institutional Animal Care and Use Committees (IACUC assurance number A3303-01).

Copyright

© 2017, Redhu et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 3,029
    views
  • 516
    downloads
  • 31
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Naresh S Redhu
  2. Vasudevan Bakthavatchalu
  3. Evan A Conaway
  4. Dror S Shoval
  5. Amy M Tsou
  6. Jeremy A Goettel
  7. Amlan Biswas
  8. Chuanwu Wang
  9. Michael Field
  10. Werner Muller
  11. Andre Bleich
  12. Ning Li
  13. Georg K Gerber
  14. Lynn Bry
  15. James G Fox
  16. Scott B Snapper
  17. Bruce H Horwitz
(2017)
Macrophage dysfunction initiates colitis during weaning of infant mice lacking the interleukin-10 receptor
eLife 6:e27652.
https://doi.org/10.7554/eLife.27652

Share this article

https://doi.org/10.7554/eLife.27652

Further reading

    1. Computational and Systems Biology
    2. Immunology and Inflammation
    Peng Li, Sree Pulugulla ... Warren J Leonard
    Short Report

    Transcription factor partners can cooperatively bind to DNA composite elements to augment gene transcription. Here, we report a novel protein-DNA binding screening pipeline, termed Spacing Preference Identification of Composite Elements (SPICE), that can systematically predict protein binding partners and DNA motif spacing preferences. Using SPICE, we successfully identified known composite elements, such as AP1-IRF composite elements (AICEs) and STAT5 tetramers, and also uncovered several novel binding partners, including JUN-IKZF1 composite elements. One such novel interaction was identified at CNS9, an upstream conserved noncoding region in the human IL10 gene, which harbors a non-canonical IKZF1 binding site. We confirmed the cooperative binding of JUN and IKZF1 and showed that the activity of an IL10-luciferase reporter construct in primary B and T cells depended on both this site and the AP1 binding site within this composite element. Overall, our findings reveal an unappreciated global association of IKZF1 and AP1 and establish SPICE as a valuable new pipeline for predicting novel transcription binding complexes.

    1. Immunology and Inflammation
    2. Medicine
    Edwin A Homan, Ankit Gilani ... James C Lo
    Short Report

    Together with obesity and type 2 diabetes, metabolic dysfunction-associated steatotic liver disease (MASLD) is a growing global epidemic. Activation of the complement system and infiltration of macrophages has been linked to progression of metabolic liver disease. The role of complement receptors in macrophage activation and recruitment in MASLD remains poorly understood. In human and mouse, C3AR1 in the liver is expressed primarily in Kupffer cells, but is downregulated in humans with MASLD compared to obese controls. To test the role of complement 3a receptor (C3aR1) on macrophages and liver resident macrophages in MASLD, we generated mice deficient in C3aR1 on all macrophages (C3aR1-MφKO) or specifically in liver Kupffer cells (C3aR1-KpKO) and subjected them to a model of metabolic steatotic liver disease. We show that macrophages account for the vast majority of C3ar1 expression in the liver. Overall, C3aR1-MφKO and C3aR1-KpKO mice have similar body weight gain without significant alterations in glucose homeostasis, hepatic steatosis and fibrosis, compared to controls on a MASLD-inducing diet. This study demonstrates that C3aR1 deletion in macrophages or Kupffer cells, the predominant liver cell type expressing C3ar1, has no significant effect on liver steatosis, inflammation or fibrosis in a dietary MASLD model.